Bertok, T.; Jane, E.; Bertokova, A.; Lorencova, L.; Zvara, P.; Smolkova, B.; Kucera, R.; Klocker, H.; Tkac, J.
Validating fPSA Glycoprofile as a Prostate Cancer Biomarker to Avoid Unnecessary Biopsies and Re-Biopsies. Cancers 2020, 12, 2988.
https://doi.org/10.3390/cancers12102988
AMA Style
Bertok T, Jane E, Bertokova A, Lorencova L, Zvara P, Smolkova B, Kucera R, Klocker H, Tkac J.
Validating fPSA Glycoprofile as a Prostate Cancer Biomarker to Avoid Unnecessary Biopsies and Re-Biopsies. Cancers. 2020; 12(10):2988.
https://doi.org/10.3390/cancers12102988
Chicago/Turabian Style
Bertok, Tomas, Eduard Jane, Aniko Bertokova, Lenka Lorencova, Peter Zvara, Bozena Smolkova, Radek Kucera, Helmut Klocker, and Jan Tkac.
2020. "Validating fPSA Glycoprofile as a Prostate Cancer Biomarker to Avoid Unnecessary Biopsies and Re-Biopsies" Cancers 12, no. 10: 2988.
https://doi.org/10.3390/cancers12102988
APA Style
Bertok, T., Jane, E., Bertokova, A., Lorencova, L., Zvara, P., Smolkova, B., Kucera, R., Klocker, H., & Tkac, J.
(2020). Validating fPSA Glycoprofile as a Prostate Cancer Biomarker to Avoid Unnecessary Biopsies and Re-Biopsies. Cancers, 12(10), 2988.
https://doi.org/10.3390/cancers12102988